- You are viewing a Navigating Care library resource.
- Go to Library
Treatment of Acute Promyelocytic Leukemia (APL)
For information about the treatments listed below, see the Treatment Option Overview section.
Treatment of newly diagnosed acute promyelocytic leukemia (APL) includes:
- All-trans retinoic acid (ATRA) plus arsenic trioxide (ATO) for low-risk to intermediate-risk disease.
- ATRA plus combination chemotherapy followed by ATO for high-risk disease.
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Learn more:
- General Information About Acute Myeloid Leukemia
- Stages of Acute Myeloid Leukemia
- Treatment Option Overview
- Treatment of Untreated Acute Myeloid Leukemia
- Treatment of Acute Myeloid Leukemia in Remission
- Treatment of Refractory or Recurrent Acute Myeloid Leukemia
- Treatment of Acute Promyelocytic Leukemia (APL)
- Treatment of Recurrent Acute Promyelocytic Leukemia (APL)
- To Learn More About Adult Acute Myeloid Leukemia Cancer
Related Articles
- General Information About Acute Myeloid Leukemia
- Stages of Acute Myeloid Leukemia
- Treatment Option Overview
- Treatment of Untreated Acute Myeloid Leukemia
- Treatment of Acute Myeloid Leukemia in Remission
- Treatment of Refractory or Recurrent Acute Myeloid Leukemia
- Treatment of Acute Promyelocytic Leukemia (APL)
- Treatment of Recurrent Acute Promyelocytic Leukemia (APL)
- To Learn More About Adult Acute Myeloid Leukemia Cancer